isoxazoles has been researched along with Coronary Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gurbel, PA; Malinin, AI; O'connor, CM; Serebruany, VL | 1 |
| Gregory, CR | 1 |
1 review(s) available for isoxazoles and Coronary Disease
| Article | Year |
|---|---|
Immunosuppressive approaches to the prevention of graft vascular disease.
Topics: Coronary Disease; Cyclosporine; Heart Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppression Therapy; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mycophenolic Acid; Polyenes; Postoperative Complications; Sirolimus; Tacrolimus | 1998 |
1 trial(s) available for isoxazoles and Coronary Disease
| Article | Year |
|---|---|
Effects of roxifiban on platelet aggregation and major receptor expression in patients with coronary artery disease for the Roxifiban Oral Compound Kinetics Evaluation Trial-I (ROCKET-I Platelet Substudy).
Topics: Amidines; Aspirin; Coronary Disease; Coronary Thrombosis; Double-Blind Method; Female; Flow Cytometry; Humans; Isoxazoles; Male; Middle Aged; Platelet Aggregation; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Statistics, Nonparametric; Thrombolytic Therapy | 2003 |